NCT05711576

Brief Summary

To evaluate the naturally occurring peri-implant mucositis (PM) treatment by means of non-surgical sub-marginal peri-implant instrumentation (NSPI) with or without full-mouth disinfection approach (FMD). Specifically, the primary outcome of the present study compared the efficacy of NSPI and full-mouth disinfection (FMD) with respect to NSPI and placebo in the treatment of PM at 6 months follow-up. The secondary outcome evaluated the influence of possible predictors on the BOP changes among all follow-up sessions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 26, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 3, 2023

Completed
26 days until next milestone

Study Start

First participant enrolled

March 1, 2023

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 20, 2024

Completed
8 days until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2024

Completed
Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

12 months

First QC Date

December 26, 2022

Last Update Submit

September 3, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Bleeding on probing (BOP) changes

    The number of implants presenting with complete absence of BOP or implants with limited extent of BOP (≤1 spot/implant-the presence of a single spot)

    6-months

Secondary Outcomes (5)

  • Probing pocket depth (PPD) changes

    6-months

  • Full mouth plaque score (FMPS) % changes

    6-months

  • Full mouth bleeding score (FMBS) % changes

    6-months

  • Plaque at implant sites according to modified gingival index (mGI) changes score

    6-months

  • Plaque at implant sites according to modified plaque index (mPlI) changes score

    6-months

Study Arms (2)

non-surgical sub-marginal peri-implant instrumentation (NSPI) with placebo mouthwash

PLACEBO COMPARATOR

Patients received a one-session of non-surgical sub-marginal peri-implant instrumentation (NSPI) with placebo mouthwash

Other: Placebo mouthwash

non-surgical sub-marginal peri-implant instrumentation (NSPI) with FMD

ACTIVE COMPARATOR

Patients received a one-session of non-surgical sub-marginal peri-implant instrumentation (NSPI) with full-mouth disinfection approach (FMD).

Other: Full mouth disinfection

Interventions

Patients were treated with non surgical peri-implant mucositis therapy with non-surgical sub-marginal peri-implant instrumentation plus the use of a placebo mouthwash

non-surgical sub-marginal peri-implant instrumentation (NSPI) with placebo mouthwash

Patients were treated with non surgical peri-implant mucositis therapy with non-surgical sub-marginal peri-implant instrumentation plus the use of full mouth disinfection (FMD) approach

non-surgical sub-marginal peri-implant instrumentation (NSPI) with FMD

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age ≥18 years old;
  • implants with smooth necks supporting cemented or screw-retained single-unit crowns with at least one BOP-positive site (Berglundh et al., 2018),
  • implants placed in both maxilla and mandible
  • patients with gingivitis or treated periodontitis with the absence of residual PD ≥5 mm
  • presence at least of 2 mm of keratinized mucosa (KT) at implant sites

You may not qualify if:

  • presence of systemic diseases;
  • pregnancy or lactating;
  • use of inflammatory drugs or antibiotics within 3 months prior to study recruitment;
  • implants with modified (i.e., micro-rough) necks;
  • interproximal open contacts between implant restoration and adjacent teeth;
  • peri-implantitis (Berglundh et al., 2018)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

AOU Policlinico G. Rodolico

Catania, 95124, Italy

Location

Study Officials

  • Gaetano Isola

    Università degli Studi di Catania

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Sealed envelopes
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: At baseline, 1, 3, 6 months, full-mouth plaque score (FMPS), full-mouth bleeding score (FMBS), probing depth (PD), bleeding on probing (BOP), modified gingival index (mGI), and modified plaque index (mPlI) were assessed.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 26, 2022

First Posted

February 3, 2023

Study Start

March 1, 2023

Primary Completion

February 20, 2024

Study Completion

February 28, 2024

Last Updated

September 19, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will share

Results and clinical protocol

Shared Documents
STUDY PROTOCOL
Time Frame
6-months
Access Criteria
Official university website/pubmed

Locations